These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 17725207

  • 1. [New management of phosphocalcic abnormalities in dialysis patient].
    Delanaye P, Van Overmeire L, Dusbois BE, Krzesinski JM.
    Rev Med Liege; 2007; 62(5-6):360-5. PubMed ID: 17725207
    [Abstract] [Full Text] [Related]

  • 2. [Therapeutic options for mineral metabolism disorders in dialysis patients: a case report].
    Cozzolino M, Pasho S, Missaglia E, Crovetto C, Fallabrino G, Brancaccio D.
    G Ital Nefrol; 2008; 25(2):234-7. PubMed ID: 18350504
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of secondary hyperparathyroidism resistant to conventional therapy and tertiary hyperparathyroidism with Cinacalcet: an efficiency strategy].
    Jean G, Vanel T, Terrat JC, Hurot JM, Lorriaux C, Mayor B, Deleaval P, Vovan C, Chazot C.
    Nephrol Ther; 2010 Apr; 6(2):105-10. PubMed ID: 20185380
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [German observational trial on secondary hyperparathyroidism therapy with cinacalcet (EARLY)].
    Reichel H, Braun J.
    Dtsch Med Wochenschr; 2011 Jan; 136(4):123-8. PubMed ID: 21181622
    [Abstract] [Full Text] [Related]

  • 6. Implementation of 'K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease' after the introduction of cinacalcet in a population of patients on chronic haemodialysis.
    Arenas MD, Alvarez-Ude F, Gil MT, Moledous A, Malek T, Nuñez C, Devesa R, Carretón MA, Soriano A.
    Nephrol Dial Transplant; 2007 Jun; 22(6):1639-44. PubMed ID: 17277339
    [Abstract] [Full Text] [Related]

  • 7. Cinacalcet for managing secondary hyperparathyroidism in dialysis patients in clinical practice in Belgium: a 16-month observational study (ECHO-B).
    Debelle F, Meeus G, Dratwa M, Maes B, Vanholder R, Albert A, Schutyser E, Jadoul M.
    Acta Clin Belg; 2013 Jun; 68(4):275-81. PubMed ID: 24455797
    [Abstract] [Full Text] [Related]

  • 8. Management of calcium, phosphorus and bone metabolism in dialysis patients using sevelamer hydrochloride and vitamin D therapy.
    Ishida M, Yao N, Yachiku S, Anzai T, Kobayashi T, Ishida H.
    Ther Apher Dial; 2005 Aug; 9 Suppl 1():S16-21. PubMed ID: 16109136
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of cinacalcet cessation on hyperparathyroidism in kidney transcaplant patients after long-term dialysis therapy.
    Nakai K, Fujii H, Yoshikawa M, Kono K, Yonekura Y, Goto S, Ishimura T, Takeda M, Fujisawa M, Nishi S.
    Clin Exp Nephrol; 2015 Dec; 19(6):1184-8. PubMed ID: 25782729
    [Abstract] [Full Text] [Related]

  • 13. 11. Vitamin D in the therapy of disorders of calcium and phosphorus metabolism.
    Kumar R, Riggs BL.
    Mayo Clin Proc; 1981 May; 56(5):327-33. PubMed ID: 6262583
    [No Abstract] [Full Text] [Related]

  • 14. [Analysis of the efficacy and factors influencing the response of secondary hyperparathyroidism patients on hemodialysis to cinacalcet].
    Segura Torres P, Borrego Utiel FJ, Sánchez Perales MC, García Cortés MJ, Biechy Baldán MM, Pérez Bañasco V.
    Nefrologia; 2010 May; 30(4):443-51. PubMed ID: 20651886
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
    Torres PU.
    J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
    [Abstract] [Full Text] [Related]

  • 18. Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.
    Dong BJ.
    Clin Ther; 2005 Nov; 27(11):1725-51. PubMed ID: 16368445
    [Abstract] [Full Text] [Related]

  • 19. [Clinical application of calcimimetics].
    Nishi H, Fukagawa M.
    Clin Calcium; 2004 May; 14(5):756-9. PubMed ID: 15577038
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.